Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07601581 · ClinicalTrials.gov registry record · NA
A Trial to Determine People's Explicit vs. Implicit Preferences for Gender-inclusive Sexual and Reproductive Health Content
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 454
- Enrollment target
NCT07601581: Completed NA study, sponsored by Boston Children's Hospital.
NCT07601581 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 454 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07601581, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 454 participants
- Enrollment target
Study Summary
Participants will be shown two different versions of health content and asked which they prefer.
Primary Outcome
For each piece of content, participants will rate the following questions on a scale from strongly agree to strongly disagree: 1) I found this content easy to understand, 2) I found this content to be reliable, 3) I found this content to be biased, 4) This content is meant for people like me, 5) This content is relevant to people like me. Higher scores mean the person agreed with more positive statements.
Interventions
- BEHAVIORAL Read reproductive health material and review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 454 participants |
| Start Date | 2024-12-30 |
| Est. Completion | 2025-03-01 |
| Phase | NA |
What the finished NCT07601581 record still lists
NCT07601581 is an interventional study that assigns participants to a tested intervention. The registered 454 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 1 intervention - of which Read reproductive health material and review is the first listed.
NCT07601581 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07601581 about?
NCT07601581 is a clinical study titled "A Trial to Determine People's Explicit vs. Implicit Preferences for Gender-inclusive Sexual and Reproductive Health Content". Participants will be shown two different versions of health content and asked which they prefer.
What is the current status of trial NCT07601581?
This trial is currently completed. It is a NA study. The enrollment target is 454 participants. The study started on 2024-12-30. Estimated completion is 2025-03-01.
What interventions are being tested in trial NCT07601581?
The interventions under investigation include: Read reproductive health material and review (BEHAVIORAL).
Who is sponsoring clinical trial NCT07601581?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07601581's enrollment target sits among peer trials
454 224th of 2000 higher than 1,776 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- NCT05655936 · 454 participants · NA
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
- NCT06510374 · 454 participants · Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
- NCT06935357 · 454 participants · Phase 3
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI